Search Results - "Holland, Carolyn A"
-
1
Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in Western Kenya
Published in PloS one (05-03-2009)“…The antigen, falciparum malaria protein 1 (FMP1), represents the 42-kDa C-terminal fragment of merozoite surface protein-1 (MSP-1) of the 3D7 clone of P…”
Get full text
Journal Article -
2
Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research
Published in Vaccine (24-04-2008)“…Summary Background Immunization with RTS,S/AS02 consistently protects some vaccinees against malaria infection in experimental challenges and in field trials…”
Get full text
Journal Article -
3
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
Published in Vaccine (02-01-2007)“…Abstract We report the first trial of candidate malaria vaccine antigen FMP1, a 42 kDa fragment from the C-terminus of merozoite surface protein-1 (MSP-1) from…”
Get full text
Journal Article -
4
Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A
Published in Vaccine (08-05-2006)“…RTS,S/AS02A, a recombinant Plasmodium falciparum vaccine based on the circumsporozoite protein (CSP) repeat and C-terminus regions, elicits strong humoral and…”
Get full text
Journal Article -
5
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan children
Published in PLoS clinical trials (24-11-2006)“…Our aim was to evaluate the safety, reactogenicity, and immunogenicity of an investigational malaria vaccine. This was an age-stratified phase Ib,…”
Get full text
Journal Article -
6
Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys
Published in The American journal of tropical medicine and hygiene (01-05-2004)“…Malaria vaccine RTS,S combined with thrombospondin-related anonymous protein (TRAP) and formulated with AS02A (RTS,S+TRAP/AS02A) is safe and immunogenic in…”
Get more information
Journal Article -
7
Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries ofPlasmodium falciparumcircumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A
Published in Vaccine (08-05-2006)“…Background RTS,S/AS02A, a recombinantPlasmodium falciparumvaccine based on the circumsporozoite protein (CSP) repeat and C-terminus regions, elicits strong…”
Get full text
Journal Article -
8
Phase 1 randomized double-blind safety and immunogenicity trial ofPlasmodium falciparummalaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
Published in Vaccine (02-01-2007)“…We report the first trial of candidate malaria vaccine antigen FMP1, a 42kDa fragment from the C-terminus of merozoite surface protein-1 (MSP-1) from the 3D7…”
Get full text
Journal Article